Francesca Gay, MD, on the FORTE Trial: Triplet Therapy for Newly Diagnosed Multiple Myeloma

Posted: Monday, June 10, 2019

Francesca Gay, MD, of GIMEMA, European Myeloma Network, discusses the potential role of carfilzomib/lenalidomide/dexamethasone with or without transplantation in inducing high-quality responses, achieving negative minimal residual disease, and reducing the risk of early relapse.